ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,823 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentZurichEvlaBio AG
EvlaBio AG Logo
Verified· 2 sources

EvlaBio AG

Summary

About the company

The core activity of EvlaBio AG is the development of therapeutics, particularly first-in-class therapeutics in the field of cardiovascular and cardio-renal diseases. The focus is on the development of therapeutic monoclonal antibodies (mAb) that target specific target molecules such as FGFR4/FGF23 to treat chronic kidney diseases (CKD).

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered1
Anti-FGFR4 antibody therapy
Targeted anti-FGFR4 monoclonal antibody therapy for the treatment of left ventricular hypertrophy in chronic kidney disease; blocks FGF23-mediated FGFR4 signals and pathological cardiac remodeling.
Comparisons

EvlaBio AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank EvlaBio AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of EvlaBio AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Seestrasse 352
8038 Zurich

At a glance

Legal form
Corporation
UID
CHE-351.033.709
Founded
2022 · 4 years
Last commercial register change
August 7, 2025
Employees
11 to 20

Knowledge

No knowledge articles yet

Once EvlaBio AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

NS
Neurimmune Subone AG
Schlieren
NA
Neurimmune AG
Schlieren
EA
evitria AG
Fahrweid
CR
Charles River Laboratories Switzerland AG
Hettlingen
PA
Philochem AG
Otelfingen
MA
Mabylon AG
Schlieren
CA
CDR-Life AG
Horgen
AB
Araris Biotech AG
Au Zh